Xuan Zheng, Matteo Haupt, M. Bähr, L. Tatenhorst, T. Doeppner
{"title":"Treating Cerebral Ischemia: Novel Therapeutic Strategies from Experimental Stroke Research","authors":"Xuan Zheng, Matteo Haupt, M. Bähr, L. Tatenhorst, T. Doeppner","doi":"10.36255/exonpublications.cerebralischemia.2021.therapy","DOIUrl":null,"url":null,"abstract":"ABSTRACT \nAlthough systemic thrombolysis and endovascular treatment have revolutionized modern stroke treatment, the majority of patients do not qualify for either treatment paradigm. Hence, novel adjuvant therapeutic strategies are required. This chapter provides an overview of our current understanding of novel therapeutic strategies in preclinical stroke models. The chapter is organized in three major parts to cover the acute, subacute, and chronic phases of ischemic stroke. The potential of various pharmacological agents, stem cells, microRNAs, and extracellular vesicles as therapeutic avenues along with the progress and challenges are discussed.","PeriodicalId":263181,"journal":{"name":"Cerebral Ischemia","volume":"23 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2021-09-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"6","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cerebral Ischemia","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.36255/exonpublications.cerebralischemia.2021.therapy","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 6
Abstract
ABSTRACT
Although systemic thrombolysis and endovascular treatment have revolutionized modern stroke treatment, the majority of patients do not qualify for either treatment paradigm. Hence, novel adjuvant therapeutic strategies are required. This chapter provides an overview of our current understanding of novel therapeutic strategies in preclinical stroke models. The chapter is organized in three major parts to cover the acute, subacute, and chronic phases of ischemic stroke. The potential of various pharmacological agents, stem cells, microRNAs, and extracellular vesicles as therapeutic avenues along with the progress and challenges are discussed.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
